|
US37913A
(en)
|
|
1863-03-17 |
|
Improvement in sewing-machines |
|
US146439A
(en)
|
|
1874-01-13 |
|
Improvement in pruning-shears |
|
US13294A
(en)
|
|
1855-07-17 |
|
Improved apparatus for cooling repeating fire-arms |
|
US37914A
(en)
|
|
1863-03-17 |
|
Improved automatic nose-bag |
|
DE1617477U
(de)
|
1950-09-27 |
1950-12-14 |
Heinrich Dressel |
Radhalter fuer raeder, beispielsweise fuer kinderwagen und kleinfahrzeuge.
|
|
US3776938A
(en)
*
|
1958-05-28 |
1973-12-04 |
S Bergstrom |
Dihydro-pge1
|
|
US3776939A
(en)
*
|
1958-05-28 |
1973-12-04 |
S Bergstrom |
Dihydro-pgf1a
|
|
US3839409A
(en)
*
|
1958-05-28 |
1974-10-01 |
Kemiska Inst Karolinska I |
Pge3 esters and alkanoates
|
|
US3069322A
(en)
*
|
1958-05-28 |
1962-12-18 |
Bergstrom Sune |
Pge and pgf
|
|
DE1801750U
(de)
|
1959-07-07 |
1959-12-10 |
H L Wahrendorf Betonwerk |
Trog zur aufnahme des weichengestaenges von eisenbahngleisen.
|
|
US3382247A
(en)
|
1965-11-01 |
1968-05-07 |
Upjohn Co |
6-amino-1, 2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidines
|
|
US3524867A
(en)
*
|
1966-06-06 |
1970-08-18 |
Upjohn Co |
Process for producing cyclopenta (b)pyrans
|
|
US3435053A
(en)
*
|
1966-06-06 |
1969-03-25 |
Upjohn Co |
Cyclopenta(b)pyrans
|
|
US3538120A
(en)
|
1967-05-22 |
1970-11-03 |
Ciba Geigy Corp |
Cyclopentyl-alkanoic acids
|
|
US3636120A
(en)
|
1967-10-09 |
1972-01-18 |
Upjohn Co |
Prostaglandin e primary alcohols
|
|
GB1285371A
(en)
|
1968-08-29 |
1972-08-16 |
Upjohn Co |
Improvements in or relating to therapeutic methods using prostaglandins
|
|
GB1251750A
(de)
|
1968-11-12 |
1971-10-27 |
|
|
|
DE1910561A1
(de)
|
1969-03-01 |
1970-09-10 |
Herten Dr Med Kurt |
Mittel zur Verhuetung von Haarausfall
|
|
BE755555A
(fr)
|
1969-09-02 |
1971-03-01 |
Richardson Merrell Inc |
Derives de quinoxaline
|
|
US3882241A
(en)
*
|
1969-12-01 |
1975-05-06 |
Upjohn Co |
Use of prostaglandins E and F for prevention of pregnancy in humans
|
|
US3896156A
(en)
*
|
1970-06-30 |
1975-07-22 |
Upjohn Co |
Dihydroprostaglandin e, analogs
|
|
IT1012505B
(it)
|
1970-09-28 |
1977-03-10 |
Imes C Spa |
Estratto di ricci di mare
|
|
BE791369A
(fr)
|
1971-11-16 |
1973-05-14 |
American Cyanamid Co |
Cyanurates de tris-(meta-hydroxybenzyle) faisant l'objet d'un empechement sterique et utilisables comme anti-oxydants
|
|
US3798275A
(en)
|
1972-04-05 |
1974-03-19 |
Ciba Geigy Corp |
Etherified mercapto-methoxyamines
|
|
US4304907A
(en)
|
1972-05-10 |
1981-12-08 |
The Upjohn Company |
Bicyclo lactone intermediates for prostaglandin analogs
|
|
US4011262A
(en)
*
|
1972-07-13 |
1977-03-08 |
Pfizer Inc. |
13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
|
|
US3974213A
(en)
|
1972-07-13 |
1976-08-10 |
Pfizer Inc. |
13,14-Dihydro-15-substituted-ω-pentanorprostaglandins
|
|
US3882245A
(en)
*
|
1972-11-01 |
1975-05-06 |
Upjohn Co |
Use of prostaglandins in combating shock
|
|
DD118856A5
(de)
|
1972-11-08 |
1976-03-20 |
|
|
|
US4152527A
(en)
|
1972-11-08 |
1979-05-01 |
Pfizer Inc. |
15-Substituted-ω-pentanorprostaglandins
|
|
IL50310A
(en)
|
1972-11-08 |
1977-08-31 |
Pfizer |
Dimethyl ketophosphonates
|
|
US4024179A
(en)
*
|
1972-11-08 |
1977-05-17 |
Pfizer Inc. |
Substituted ω-pentanorprostaglandins
|
|
US3984424A
(en)
|
1972-11-08 |
1976-10-05 |
Pfizer Inc. |
P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
|
|
JPS49101356U
(de)
|
1972-12-20 |
1974-08-31 |
|
|
|
JPS5320995Y2
(de)
|
1972-12-23 |
1978-06-02 |
|
|
|
JPS5720305B2
(de)
|
1973-02-28 |
1982-04-27 |
|
|
|
US3984455A
(en)
*
|
1973-07-16 |
1976-10-05 |
The Upjohn Company |
Prostaglandin E1 analogs
|
|
FR2239458A1
(en)
|
1973-07-31 |
1975-02-28 |
Aries Robert |
Prostaglandin amides - with antilipolytic, gonadotrophic, luteolytic, hypotensive and other activities associated with prostaglandins
|
|
DE2365101A1
(de)
*
|
1973-12-21 |
1975-07-10 |
Schering Ag |
Neue prostansaeurederivate und verfahren zu ihrer herstellung
|
|
US3931282A
(en)
|
1974-02-21 |
1976-01-06 |
Syntex (U.S.A.) Inc. |
11α-Hydroxymethyl prostaglandins
|
|
US3928588A
(en)
*
|
1974-02-22 |
1975-12-23 |
Upjohn Co |
Method of reducing the undesirable gastrointestinal effects of prostaglandin synthetase inhibitors
|
|
US4069885A
(en)
*
|
1974-03-27 |
1978-01-24 |
Klockner-Humboldt-Deutz Aktiengesellschaft |
Tractor-implement arrangement for establishing frictional engagement therebetween
|
|
DE2416193C2
(de)
*
|
1974-04-03 |
1985-08-14 |
Hoechst Ag, 6230 Frankfurt |
Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
|
|
GB1458315A
(en)
|
1974-04-22 |
1976-12-15 |
Ici Ltd |
Prostanoic acid derivatives
|
|
DE2460990A1
(de)
|
1974-12-21 |
1976-07-01 |
Hoechst Ag |
Neue prostaglandin-analoga und verfahren zu ihrer herstellung
|
|
GB1507211A
(en)
*
|
1975-02-14 |
1978-04-12 |
Ono Pharmaceutical Co |
Prostaglandin analogues
|
|
US3934013A
(en)
|
1975-02-21 |
1976-01-20 |
Syntex (U.S.A.) Inc. |
Pharmaceutical composition
|
|
US4217360A
(en)
*
|
1975-02-27 |
1980-08-12 |
Schering Aktiengesellschaft |
Novel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereof
|
|
GB1506817A
(en)
|
1975-03-31 |
1978-04-12 |
Upjohn Co |
Prostaglandins
|
|
DE2517771A1
(de)
*
|
1975-04-18 |
1976-10-28 |
Schering Ag |
Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
|
|
GB1520522A
(en)
|
1975-06-16 |
1978-08-09 |
Ono Pharmaceutical Co |
16-methyleneprostaglandins
|
|
ES449162A1
(es)
|
1975-06-23 |
1977-12-16 |
Syntex Inc |
Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
|
|
US4005133A
(en)
|
1975-10-14 |
1977-01-25 |
The Upjohn Company |
PGF2.sub.α, L-Arginine salt
|
|
US4128577A
(en)
|
1975-12-29 |
1978-12-05 |
The Upjohn Company |
15-Methyl- and 16-phenoxy-PGF2 α, amides
|
|
US4158667A
(en)
*
|
1976-02-04 |
1979-06-19 |
The Upjohn Company |
6-Keto PGF analogs
|
|
US4596812A
(en)
|
1976-05-24 |
1986-06-24 |
The Upjohn Company |
Methods and solutions for treating male pattern alopecia
|
|
US4139619A
(en)
|
1976-05-24 |
1979-02-13 |
The Upjohn Company |
6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
|
|
US4051238A
(en)
|
1976-06-03 |
1977-09-27 |
The Upjohn Company |
Treatment of genital tract diseases of domestic animals with prostaglandins
|
|
US4268522A
(en)
|
1976-06-14 |
1981-05-19 |
Pfizer Inc. |
13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
|
|
DE2635985A1
(de)
*
|
1976-08-06 |
1978-02-09 |
Schering Ag |
Prostansaeurederivat und verfahren zu ihrer herstellung
|
|
DE2737808A1
(de)
|
1976-08-27 |
1978-03-16 |
Pfizer |
2-substituierte aryl-heterocyclische omega-pentanorprostaglandine
|
|
DE2737807A1
(de)
|
1976-08-27 |
1978-03-09 |
Pfizer |
C tief 1 -p-biphenylester von omega-pentanorprostaglandinen
|
|
US4123441A
(en)
*
|
1976-09-22 |
1978-10-31 |
The Upjohn Company |
Enlarged-hetero-ring prostacyclin analogs
|
|
US4499293A
(en)
*
|
1976-09-22 |
1985-02-12 |
The Upjohn Company |
PGI2 Salts
|
|
US4089885A
(en)
*
|
1976-11-05 |
1978-05-16 |
American Home Products Corporation |
Prostaglandin derivatives
|
|
US4171331A
(en)
*
|
1978-06-05 |
1979-10-16 |
Miles Laboratories, Inc. |
1 And 2-substituted analogues of certain prostaglandins
|
|
US4178457A
(en)
|
1978-07-10 |
1979-12-11 |
Syntex (U.S.A.) Inc. |
(dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof
|
|
US4206151A
(en)
|
1978-12-21 |
1980-06-03 |
American Cyanamid Company |
15-Deoxy-16-hydroxy-16-vinyl or cyclopropyl prostan-1-ols of the E, A and F series
|
|
US4311707A
(en)
|
1979-02-12 |
1982-01-19 |
American Cyanamid Company |
Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
|
|
GB2048254B
(en)
|
1979-04-02 |
1983-05-25 |
Upjohn Co |
19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
|
|
US4225507A
(en)
*
|
1979-07-05 |
1980-09-30 |
The Upjohn Company |
19-Hydroxy-19-methyl-PGI2 compounds
|
|
US4225508A
(en)
*
|
1979-07-05 |
1980-09-30 |
The Upjohn Company |
19-Hydroxy-PGI2 compounds
|
|
US4296504A
(en)
|
1980-07-07 |
1981-10-27 |
Lawson Daniel C |
Toilet seat lock
|
|
JPH0222226Y2
(de)
|
1981-02-04 |
1990-06-14 |
|
|
|
US4621100A
(en)
*
|
1981-09-25 |
1986-11-04 |
The Upjohn Company |
Treatment of osteoporosis with prostaglandins
|
|
US4543353A
(en)
|
1981-11-27 |
1985-09-24 |
Farmitalia Carlo Erba S.P.A. |
Ester and amide derivatives of 13,14-didehydro prostaglandins
|
|
US4599353A
(en)
|
1982-05-03 |
1986-07-08 |
The Trustees Of Columbia University In The City Of New York |
Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
|
|
US4912235A
(en)
|
1983-12-22 |
1990-03-27 |
Syntex (U.S.A.) Inc. |
Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
|
|
WO1986000616A1
(en)
|
1984-07-13 |
1986-01-30 |
Gail Sansone Bazzano |
Substituted pyrimidine oxides useful for hair growth promotion
|
|
AU573018B2
(en)
|
1984-07-31 |
1988-05-26 |
Syntex (U.S.A.) Inc. |
11-substituted 16-phenoxy prostatrienoic acid derivatives
|
|
JPS61126069A
(ja)
|
1984-11-21 |
1986-06-13 |
Res Dev Corp Of Japan |
プロスタグランジン誘導体
|
|
JPS61218510A
(ja)
*
|
1985-03-22 |
1986-09-29 |
Dai Ichi Seiyaku Co Ltd |
毛髪用剤
|
|
US4757089A
(en)
|
1985-06-14 |
1988-07-12 |
Massachusetts Eye And Ear Infirmary |
Increasing aqueous humor outflow
|
|
US5863948A
(en)
|
1985-06-14 |
1999-01-26 |
Massachusetts Eye And Ear Infirmary |
Increasing aqueous humor outflow
|
|
US4704386A
(en)
*
|
1985-08-29 |
1987-11-03 |
G. D. Searle & Co. |
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[(phenylsulfinyl-, and phenylsulfonyl)alkanoyl]hydrazides
|
|
US4883819A
(en)
|
1986-07-31 |
1989-11-28 |
The Trustees Of Columbia University In The City Of New York |
Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
|
|
FI872552A7
(fi)
*
|
1986-06-09 |
1987-12-10 |
American Cyanamid Co |
Paikallisesti käytettävä prostaglandiinikoostumus.
|
|
US4889845A
(en)
*
|
1986-06-09 |
1989-12-26 |
American Cyanamid Company |
Vehicle for topical application of pharmaceuticals
|
|
US5041439A
(en)
|
1986-06-13 |
1991-08-20 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions
|
|
US5663203A
(en)
*
|
1986-09-11 |
1997-09-02 |
Schering Aktiengesellschaft |
Agents containing prostacyclin derivatives for topical application
|
|
US5500230A
(en)
*
|
1987-01-23 |
1996-03-19 |
The General Hospital Corporation |
Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
|
|
US5219885A
(en)
*
|
1987-02-16 |
1993-06-15 |
Froelich Juergen |
Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
|
|
US4952581A
(en)
|
1987-04-03 |
1990-08-28 |
The Trustees Of Columbia University In The City Of New York |
Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
|
|
US5591887A
(en)
*
|
1987-04-30 |
1997-01-07 |
R-Tech Ueno, Ltd. |
Prostaglandins of the F series
|
|
GB8713747D0
(en)
|
1987-06-12 |
1987-07-15 |
Unilever Plc |
Skin treatment composition
|
|
US5166178B1
(en)
|
1987-09-18 |
1998-07-21 |
R Tech Ueno Ltd |
Ocular hypotensive agents
|
|
GB2209939B
(en)
|
1987-09-18 |
1992-01-02 |
R Tech Ueno Ltd |
The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
|
|
ES2317964T5
(es)
|
1988-09-06 |
2015-02-20 |
Pfizer Health Ab |
Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
|
|
US5321128A
(en)
|
1988-09-06 |
1994-06-14 |
Kabi Pharmacia Ab |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US5296504A
(en)
|
1988-09-06 |
1994-03-22 |
Kabi Pharmacia |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US6187813B1
(en)
|
1990-04-10 |
2001-02-13 |
Pharmacia & Upjohn Aktiebolag |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
US5194429A
(en)
|
1988-10-01 |
1993-03-16 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Ocular hypotensive agents
|
|
US4968812A
(en)
|
1989-06-23 |
1990-11-06 |
Shell Oil Company |
Spirolactonelactams
|
|
JPH0737389B2
(ja)
|
1989-08-29 |
1995-04-26 |
久光製薬株式会社 |
プロスタグランジンｅ１含有の軟膏剤
|
|
CA1339132C
(en)
|
1989-09-12 |
1997-07-29 |
Johan W. Stjernschantz |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
CA2030345C
(en)
|
1989-11-22 |
1998-12-08 |
Ryuji Ueno |
Use of 15-keto-prostaglandin compound for improvement of encephalic function
|
|
JPH0627942Y2
(ja)
|
1989-12-14 |
1994-07-27 |
松下電器産業株式会社 |
ヒューズホルダー付コンデンサー
|
|
WO1991013207A1
(en)
|
1990-02-21 |
1991-09-05 |
Pulp And Paper Research Institute Of Canada |
POLY-β-HYDROXYALKANOATES FOR USE IN FIBRE CONSTRUCTS AND FILMS
|
|
TW224942B
(de)
|
1990-04-04 |
1994-06-11 |
Adka Ueno Kk |
|
|
US5302617A
(en)
|
1990-04-27 |
1994-04-12 |
Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio |
Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
|
|
US5063057A
(en)
*
|
1990-09-26 |
1991-11-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Cosmetic capsules
|
|
DE4024347A1
(de)
|
1990-07-27 |
1992-01-30 |
Schering Ag |
Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
|
JPH04300833A
(ja)
|
1991-03-29 |
1992-10-23 |
Green Cross Corp:The |
プロスタグランジンｅ１ 含有脂肪乳剤充填噴霧剤
|
|
US5378840A
(en)
*
|
1992-04-16 |
1995-01-03 |
G. D. Searle & Co. |
Substituted dibenzoxazepine compounds
|
|
US5312832A
(en)
|
1991-05-17 |
1994-05-17 |
Allergan, Inc. |
Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
|
|
US5288754A
(en)
|
1992-02-04 |
1994-02-22 |
Allergan, Inc. |
Polar C-1 esters of prostaglandins
|
|
US5641494A
(en)
*
|
1992-03-20 |
1997-06-24 |
Janssen Pharmaceutica N.V. |
Agent for regulating the greasiness of the skin
|
|
US5578643A
(en)
*
|
1992-05-20 |
1996-11-26 |
Loyola University Of Chicago |
Protective prostaglandins for use in conjunction with chemotherapeutic agents
|
|
US5422371A
(en)
*
|
1992-05-27 |
1995-06-06 |
Arch Development Corp. |
Methods and compositions for inhibiting 5α-reductase activity
|
|
JP3102141B2
(ja)
*
|
1992-05-29 |
2000-10-23 |
東レ株式会社 |
養毛育毛剤
|
|
US5817694A
(en)
*
|
1992-06-08 |
1998-10-06 |
New Pharma International Corp. |
16-methyl-11,16-dihydroxy-9-oxoprost-2,13-dien-1-oic acid and derivatives
|
|
US5409911A
(en)
|
1992-09-11 |
1995-04-25 |
Merck & Co., Inc. |
Prostaglandin analog for treating osteoporosis
|
|
US5834498A
(en)
*
|
1992-09-21 |
1998-11-10 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5352708A
(en)
|
1992-09-21 |
1994-10-04 |
Allergan, Inc. |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
|
US5688819A
(en)
|
1992-09-21 |
1997-11-18 |
Allergan |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
|
US5972991A
(en)
*
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
EP0664707B1
(de)
|
1992-10-13 |
1997-06-04 |
Alcon Laboratories, Inc. |
Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
|
|
US5332730A
(en)
|
1992-10-16 |
1994-07-26 |
Allergan, Inc. |
Azido derivatives of cyclopentane heptanoic or heptenoic acid
|
|
US5340813A
(en)
*
|
1992-11-09 |
1994-08-23 |
Cell Therapeutics, Inc. |
Substituted aminoalkyl xanthine compounds
|
|
DE4238830A1
(de)
*
|
1992-11-17 |
1994-05-19 |
Anton Felder |
Verfahren zum hydraulischen Verzweigen einer offenen Strömung sowie hydraulisch arbeitende Kanalverzweigung
|
|
US5670506A
(en)
*
|
1993-04-05 |
1997-09-23 |
Cell Therapeutics, Inc. |
Halogen, isothiocyanate or azide substituted xanthines
|
|
US5395932A
(en)
*
|
1993-04-30 |
1995-03-07 |
G. D. Searle & Co. |
2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
|
|
US5985597A
(en)
*
|
1993-05-26 |
1999-11-16 |
Merck Frosst Canada, Inc. |
DNA encoding prostaglandin receptor EP1
|
|
ATE172471T1
(de)
|
1993-06-25 |
1998-11-15 |
Merck Frosst Canada Inc |
Prostaglandin rezeptor ep3 und kodierende dns
|
|
US5869281A
(en)
*
|
1993-06-25 |
1999-02-09 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor FP
|
|
US5510383A
(en)
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
|
US5605814A
(en)
*
|
1993-08-31 |
1997-02-25 |
Merck Frosst Canada Inc. |
DNA encoding human prostaglandin receptor EP2
|
|
US5516652A
(en)
*
|
1993-10-06 |
1996-05-14 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor IP
|
|
FR2711060B1
(fr)
|
1993-10-13 |
1995-11-17 |
Oreal |
Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
|
|
SE9303444D0
(sv)
|
1993-10-20 |
1993-10-20 |
Kabi Pharmacia Ab |
New use of prostaglandins
|
|
WO1995011033A1
(en)
|
1993-10-22 |
1995-04-27 |
Commonwealth Scientific And Industrial Research Organisation |
Polyoxometallates in the treatment of flavivirus infections
|
|
SE9303627D0
(sv)
|
1993-11-03 |
1993-11-03 |
Kabi Pharmacia Ab |
Method and means for prevention of cataract
|
|
US5431881A
(en)
|
1993-12-10 |
1995-07-11 |
Palacios; Henry J. |
Treatment of hair loss and dermatological problems
|
|
KR100345943B1
(ko)
*
|
1993-12-20 |
2002-11-30 |
후지사와 야꾸힝 고교 가부시키가이샤 |
4,5-디아릴옥사졸유도체
|
|
US5545665A
(en)
*
|
1993-12-28 |
1996-08-13 |
Allergan |
Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
|
|
US6124344A
(en)
|
1993-12-28 |
2000-09-26 |
Allergan Sales, Inc. |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5458883A
(en)
|
1994-01-12 |
1995-10-17 |
Duke University |
Method of treating disorders of the eye
|
|
US5462968A
(en)
|
1994-01-19 |
1995-10-31 |
Allergan, Inc. |
EP2 -receptor agonists as agents for lowering intraocular pressure
|
|
ZA95627B
(en)
|
1994-01-28 |
1995-10-05 |
Procter & Gamble |
Biodegradable copolymers and plastic articles comprising biodegradable copolymers
|
|
US5476372A
(en)
|
1994-02-10 |
1995-12-19 |
Yang; Hsi-Kung |
Manual pump
|
|
SE9403158D0
(sv)
*
|
1994-09-21 |
1994-09-21 |
Pharmacia Ab |
New use of prostaglandins
|
|
US5698733A
(en)
|
1994-09-30 |
1997-12-16 |
Alcon Laboratories, Inc. |
Use of 9-deoxy prostaglandin derivatives to treat glaucoma
|
|
US5885974A
(en)
*
|
1994-12-06 |
1999-03-23 |
Michael M. Danielov |
Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
|
|
US6043264A
(en)
*
|
1995-01-06 |
2000-03-28 |
Toray Industries, Inc. |
Benzene-condensed heterocyclic derivatives and their uses
|
|
WO1996023066A2
(en)
*
|
1995-01-26 |
1996-08-01 |
Merck Frosst Canada Inc. |
Prostaglandin receptor, dp
|
|
FR2730811B1
(fr)
|
1995-02-17 |
1997-03-21 |
Oreal |
Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire
|
|
US5885766A
(en)
*
|
1995-02-17 |
1999-03-23 |
Societe L'oreal S.A. |
Method of screening of substances for their effect on the expression of mediators of inflammation in a hair follicle
|
|
CA2221110C
(en)
|
1995-05-18 |
2009-08-04 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
|
|
US6169111B1
(en)
|
1995-06-07 |
2001-01-02 |
Alcon Laboratories, Inc. |
Conformationally rigid aryl prostaglandins for use in glaucoma therapy
|
|
WO1997001534A1
(en)
*
|
1995-06-26 |
1997-01-16 |
Teijin Limited |
Prostaglandins and process for producing the same
|
|
TW401408B
(en)
|
1995-07-21 |
2000-08-11 |
Fujisawa Pharmaceutical Co |
Heterocyclic compounds having prostaglandin I2 agonism
|
|
HUP9601442A3
(en)
*
|
1995-07-25 |
1999-03-29 |
Panacea Biotec Ltd |
Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
|
|
US5661178A
(en)
|
1995-09-01 |
1997-08-26 |
Allergan |
Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
|
|
US6251436B1
(en)
|
1995-09-29 |
2001-06-26 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
|
WO1997015319A1
(en)
|
1995-10-23 |
1997-05-01 |
Queen's University At Kingston |
Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1
|
|
US6441047B2
(en)
|
1995-11-17 |
2002-08-27 |
Alcon Manufacturing Ltd.. |
Combination therapy for treating glaucoma
|
|
US5814660A
(en)
|
1995-12-22 |
1998-09-29 |
Alcon Laboratories, Inc. |
9-oxa prostaglandin analogs as ocular hypotensives
|
|
AU1138097A
(en)
|
1995-12-22 |
1997-07-17 |
Alcon Laboratories, Inc. |
Combinations of prostaglandins and miotics for lowering intraocular pressure
|
|
WO1997023225A1
(en)
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinations of dp and fp type prostaglandins for lowering iop
|
|
US5994397A
(en)
|
1995-12-22 |
1999-11-30 |
Alcon Laboratories, Inc. |
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
|
US5866602A
(en)
|
1995-12-22 |
1999-02-02 |
Alcon Laboratories, Inc. |
Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
US5703108A
(en)
*
|
1996-02-28 |
1997-12-30 |
Pfizer Inc. |
Bone deposition by certain prostaglandin agonists
|
|
US5741810A
(en)
|
1996-02-29 |
1998-04-21 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
|
|
US5658897A
(en)
*
|
1996-04-08 |
1997-08-19 |
Allergan |
Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents
|
|
US5990168A
(en)
|
1996-04-18 |
1999-11-23 |
Alberta Cancer Board |
Methods and compositions for the treatment of ataxia telangiectasia
|
|
JP3049593B2
(ja)
*
|
1996-05-01 |
2000-06-05 |
株式会社ビメーク |
育毛・養毛剤
|
|
AU3588797A
(en)
|
1996-07-03 |
1998-01-21 |
Board Of Regents Of The University Of Oklahoma, The |
Enhancement of skin pigmentation by prostaglandins
|
|
US5792851A
(en)
*
|
1996-09-03 |
1998-08-11 |
Albert Einstin College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Human prostaglandin transporter
|
|
ATE221048T1
(de)
|
1996-09-17 |
2002-08-15 |
Asahi Glass Co Ltd |
Fluorierte prostaglandinderivate und medikamente
|
|
US5827508A
(en)
|
1996-09-27 |
1998-10-27 |
The Procter & Gamble Company |
Stable photoprotective compositions
|
|
JP3537274B2
(ja)
|
1996-10-29 |
2004-06-14 |
鐘淵化学工業株式会社 |
生分解性を有する積層体
|
|
WO1998019680A1
(en)
|
1996-11-01 |
1998-05-14 |
Alcon Laboratories, Inc. |
Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
|
|
AU5436198A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
DE69705421T2
(de)
|
1996-11-12 |
2002-05-16 |
Alcon Laboratories, Inc. |
15-fluoro-prostaglandine als augendrucksenkende mittel
|
|
AU5258698A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
CN1237157A
(zh)
|
1996-11-12 |
1999-12-01 |
阿尔康实验室公司 |
作为眼压降低剂的前列腺素的顺式－△4类似物
|
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
|
ATE390917T1
(de)
|
1996-12-20 |
2008-04-15 |
Pfizer |
Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten
|
|
JPH10265454A
(ja)
*
|
1997-01-27 |
1998-10-06 |
Ono Pharmaceut Co Ltd |
３，７−ジチアプロスタン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
|
|
DE69823852T2
(de)
*
|
1997-02-04 |
2005-05-19 |
Johnstone, Murray A., Seattle |
Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
|
|
NO317155B1
(no)
*
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
|
KR20000070903A
(ko)
|
1997-02-10 |
2000-11-25 |
오노 야꾸힝 고교 가부시키가이샤 |
11,15-ｏ-디알킬프로스타글란딘 ｅ 유도체, 이것의 제조 방법 및 이것을 유효 성분으로 함유하는 약제
|
|
CA2253717A1
(en)
|
1997-02-27 |
1998-09-03 |
Toray Industries Inc. |
Drugs for ameliorating pulmonary circulation
|
|
JP2001514628A
(ja)
|
1997-03-07 |
2001-09-11 |
アルコン ラボラトリーズ，インコーポレイテッド |
緑内障治療に用いるための１３−チアプロスタグランジン
|
|
US6030959A
(en)
*
|
1997-04-04 |
2000-02-29 |
Monsanto Company |
Gastro-specific prodrugs
|
|
JP3217293B2
(ja)
*
|
1997-04-17 |
2001-10-09 |
株式会社アールテック・ウエノ |
発毛・育毛剤
|
|
EP1007028A4
(de)
*
|
1997-05-09 |
2002-06-05 |
|
Behandlung von glaukom mit 8-iso-prostaglandinen
|
|
WO1998053809A1
(en)
|
1997-05-30 |
1998-12-03 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
WO1998058911A2
(en)
|
1997-06-23 |
1998-12-30 |
Pfizer Inc. |
Prostaglandin agonists
|
|
SE9702706D0
(sv)
|
1997-07-11 |
1997-07-11 |
Pharmacia & Upjohn Ab |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
|
|
WO1999012553A1
(en)
|
1997-09-08 |
1999-03-18 |
Idec Pharmaceuticals Corporation |
Methods for producing human antibodies in scid mice using dendritic cells
|
|
WO1999012556A1
(en)
|
1997-09-08 |
1999-03-18 |
The Public Health Research Institute Of The City Of New York, Inc. |
HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
|
|
WO1999012899A1
(en)
*
|
1997-09-09 |
1999-03-18 |
The Procter & Gamble Company |
A process for making prostaglandin f analogs
|
|
WO1999012897A1
(en)
|
1997-09-09 |
1999-03-18 |
The Procter & Gamble Company |
A process for making epoxide intermediates
|
|
IL134839A0
(en)
*
|
1997-09-09 |
2001-05-20 |
Procter & Gamble |
Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
|
|
CA2303460C
(en)
|
1997-09-09 |
2011-06-21 |
Mariel Therapeutics, Inc. |
Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
|
|
US6156799A
(en)
|
1997-09-09 |
2000-12-05 |
The Procter & Gamble Company |
Method of increasing bone volume using non-naturally-occurring FP selective agonists
|
|
PL339297A1
(en)
|
1997-09-09 |
2000-12-04 |
Procter & Gamble |
Method of inctrasing bone volume
|
|
AU752925B2
(en)
|
1997-09-09 |
2002-10-03 |
F. Hoffmann-La Roche Ag |
Fracture healing using PTHrP analogs
|
|
DK1012137T3
(da)
*
|
1997-09-09 |
2003-03-10 |
Procter & Gamble |
Aromatiske C-16-C-20-substituerede tetrahydro-prostaglandiner og deres anvendelse som prostaglandin FP-agonister
|
|
AUPO907697A0
(en)
|
1997-09-09 |
1997-10-02 |
Day, Robert Edward |
Chemical supplementation of bone
|
|
CA2304108A1
(en)
|
1997-09-09 |
1999-03-18 |
The Regents Of The University Of California |
Inhibition of apoptotis using prosaposin receptor agonists
|
|
ES2253826T3
(es)
*
|
1997-09-09 |
2006-06-01 |
Duke University |
Prostaglandinas aromaticas tetrahidro sustituidas por c16-c20 utilizadas como agonistas fp.
|
|
AU9312598A
(en)
|
1997-09-10 |
1999-03-29 |
Allegheny University Of The Health Sciences |
Inhibitors of collagen assembly
|
|
AU731842B2
(en)
|
1997-09-10 |
2001-04-05 |
Merck & Co., Inc. |
9a-azalides as veterinary antimicrobial agents
|
|
WO1999012563A2
(en)
|
1997-09-11 |
1999-03-18 |
The Governemnt Of The United States Of America, Represented By The Department Of Health And Human Services |
Mucosal cytotoxic t lymphocyte responses
|
|
DK1011699T3
(da)
|
1997-09-11 |
2002-03-11 |
Purdue Research Foundation |
Galactosidase-modificeret submucosavæv
|
|
JP2001515707A
(ja)
|
1997-09-12 |
2001-09-25 |
スミスクライン・ビーチャム・コーポレイション |
新規原核生物ポリヌクレオチド、ポリペプチドおよびそれらの使用
|
|
WO1999013881A1
(en)
|
1997-09-17 |
1999-03-25 |
Toray Industries, Inc. |
Cervical maturing agent
|
|
WO1999015502A1
(en)
|
1997-09-19 |
1999-04-01 |
Shionogi & Co., Ltd. |
Compounds having [2.2.1]bicyclo skeleton
|
|
UA67754C2
(uk)
|
1997-10-10 |
2004-07-15 |
Пфайзер, Інк. |
Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
|
|
US6124314A
(en)
|
1997-10-10 |
2000-09-26 |
Pfizer Inc. |
Osteoporosis compounds
|
|
CA2306837C
(en)
|
1997-10-28 |
2007-05-08 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
|
AUPP010397A0
(en)
|
1997-10-30 |
1997-11-20 |
Vaisman, Jakov |
Method and composition for treatment of sexual dysfunction
|
|
AU1373499A
(en)
|
1997-11-14 |
1999-06-07 |
United Therapeutics Corporation |
Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
|
|
US5877211A
(en)
*
|
1997-11-21 |
1999-03-02 |
Allergan |
EP2 receptor agonists as neuroprotective agents for the eye
|
|
US6099870A
(en)
|
1997-12-18 |
2000-08-08 |
Johnson & Johnson Consumer Companies, Inc. |
Methods for improving the health of hair and scalp
|
|
CA2314369A1
(en)
|
1997-12-18 |
1999-06-24 |
Nathan Earl Scott |
Prostaglandin e2/f2.alpha. combination for treating impotence and enhancing sexual arousal
|
|
US6232344B1
(en)
|
1997-12-22 |
2001-05-15 |
Alcon Laboratories, Inc. |
13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension
|
|
US5955575A
(en)
|
1997-12-22 |
1999-09-21 |
Hopital Sainte-Justine |
Antagonists of G-protein-coupled receptor
|
|
WO1999032641A1
(en)
|
1997-12-22 |
1999-07-01 |
Unilever N.V. |
A process for site-directed integration of multiple copies of a gene in a mould
|
|
WO1999033794A1
(en)
|
1997-12-25 |
1999-07-08 |
Ono Pharmaceutical Co., Ltd. |
φ-CYCLOALKYL-PROSTAGLANDIN E2 DERIVATIVES
|
|
GB2330307A
(en)
|
1998-02-07 |
1999-04-21 |
Glaxo Group Ltd |
EP4 Receptor antagonists as bone resorption inhibitors
|
|
WO1999047497A2
(en)
|
1998-03-13 |
1999-09-23 |
Merck Frosst Canada & Co. |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
|
|
KR20010042286A
(ko)
|
1998-03-31 |
2001-05-25 |
데이비드 엠 모이어 |
의약으로 유용한 ｃ１１ 옥시밀 및 히드록실아미노프로스타글란딘
|
|
US6444840B1
(en)
|
1998-03-31 |
2002-09-03 |
The Procter & Gamble Co. |
C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists
|
|
ES2244208T3
(es)
|
1998-03-31 |
2005-12-01 |
Duke University |
Prostaglandinas oximil e hidroxilamino c11 utilizados como antagonistas fp.
|
|
ES2211083T3
(es)
|
1998-05-25 |
2004-07-01 |
Taisho Pharmaceutical Co., Ltd |
Derivado de prostaglandina.
|
|
US6458549B2
(en)
|
1998-06-11 |
2002-10-01 |
Winthrop-University Hospital |
Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same
|
|
US5942545A
(en)
|
1998-06-15 |
1999-08-24 |
Macrochem Corporation |
Composition and method for treating penile erectile dysfunction
|
|
US6187818B1
(en)
|
1998-06-17 |
2001-02-13 |
Pharmacia & Upjohn Company |
Prostaglandins formulation and process
|
|
WO2000002450A1
(en)
|
1998-07-08 |
2000-01-20 |
Fibrogen, Inc. |
Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives
|
|
CA2295512C
(en)
|
1998-07-14 |
2009-05-26 |
Alcon Laboratories, Inc. |
Prostaglandin product
|
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
|
CA2337349A1
(en)
|
1998-07-21 |
2000-02-03 |
Gerald S. Ponticello |
Ophthalmic compositions for treating ocular hypertension
|
|
WO2000004898A1
(en)
|
1998-07-21 |
2000-02-03 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
US6284234B1
(en)
*
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
|
WO2000009557A1
(fr)
|
1998-08-12 |
2000-02-24 |
Kazusa Dna Research Institute Foundation |
Nouveau gene et nouvelle proteine pgth codee par ce gene
|
|
EP1114816A4
(de)
|
1998-09-14 |
2002-09-04 |
Ono Pharmaceutical Co |
$g(v)-SUBSTITUIERTE PHENYL-PROSTAGLANDIN-E-DERIVATE UND SIE ALS AKTIVEN BESTANDTEIL ENTHALTENDE MEDIKAMENTE
|
|
AUPP608898A0
(en)
|
1998-09-23 |
1998-10-15 |
Fujisawa Pharmaceutical Co., Ltd. |
New use of prostaglandin E2 antagonists
|
|
US6121253A
(en)
|
1998-11-20 |
2000-09-19 |
Merck Frosst Canada & Co. |
Prostaglandin conjugates for treating or preventing bone disease
|
|
IL144765A0
(en)
|
1999-03-01 |
2002-06-30 |
Pfizer Prod Inc |
Oxamic acids and derivatives as thyroid receptor ligands
|
|
AU763715B2
(en)
|
1999-03-05 |
2003-07-31 |
Duke University |
C16 unsaturated fp-selective prostaglandins analogs
|
|
WO2000051980A1
(en)
|
1999-03-05 |
2000-09-08 |
The Procter & Gamble Company |
C16 unsaturated fp-selective prostaglandins analogs
|
|
US6894175B1
(en)
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
|
EP1202999B1
(de)
|
1999-08-04 |
2003-06-18 |
The Procter & Gamble Company |
Neue 2-decarboxy-2-phosphinico prostaglandin f analoge
|
|
ATE444324T1
(de)
|
1999-12-30 |
2009-10-15 |
Meredian Inc |
Verwendung von bioabbaubaren kunstoffgegenständen zum servieren von nahrungsmittel
|
|
US6548535B2
(en)
|
2000-01-18 |
2003-04-15 |
Merck & Co., Inc. |
Method for treating ocular hypertension
|
|
IL143477A
(en)
|
2001-05-31 |
2009-07-20 |
Finetech Pharmaceutical Ltd |
Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
US20020146439A1
(en)
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
|
WO2001072268A1
(en)
|
2000-03-31 |
2001-10-04 |
Toray Industries, Inc. |
Hair growth or hair formation controlling agents
|
|
US20020037914A1
(en)
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
|
FR2812193B1
(fr)
|
2000-07-28 |
2003-10-24 |
Oreal |
Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
|
FR2812191B1
(fr)
|
2000-07-28 |
2003-10-17 |
Oreal |
Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
|
FR2812190B1
(fr)
|
2000-07-28 |
2003-01-31 |
Oreal |
Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
|
|
EP1298223A3
(de)
|
2001-09-28 |
2003-07-23 |
Pfizer Products Inc. |
Methoden die mit der A-C Wiederholungs-Z-Sequenz stromaufwärts des Aldosereduktasegens in Zusammenhang stehen
|
|
US20040082013A1
(en)
|
2002-01-24 |
2004-04-29 |
Regan John W |
Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2alpha activity and methods of treating cancer
|
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
|
US7186707B2
(en)
|
2002-04-01 |
2007-03-06 |
University Of Florida |
Prodrugs for use as ophthalmic agents
|
|
GB0208785D0
(en)
|
2002-04-17 |
2002-05-29 |
Medical Res Council |
Treatment methtods
|
|
US7320967B2
(en)
|
2002-04-23 |
2008-01-22 |
L'oreal |
Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
|
|
US6573294B1
(en)
|
2002-05-14 |
2003-06-03 |
Allergan, Inc. |
8-azaprostaglandin analogs as agents for lowering intraocular pressure
|
|
US7521530B2
(en)
|
2002-06-11 |
2009-04-21 |
Universite De Montreal |
Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
|
|
US20030199590A1
(en)
|
2002-07-25 |
2003-10-23 |
Cagle Gerald D |
Prostaglandin analogues for promotion of hair growth
|
|
JP4300833B2
(ja)
|
2003-03-17 |
2009-07-22 |
ソニー株式会社 |
半導体発光素子の製造方法
|
|
US7589233B2
(en)
|
2003-07-29 |
2009-09-15 |
Signature R&D Holdings, Llc |
L-Threonine derivatives of high therapeutic index
|
|
US7045634B2
(en)
|
2003-09-05 |
2006-05-16 |
Allergan, Inc. |
Prostamide receptor antagonists
|
|
US20050058614A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
|
|
US7070768B2
(en)
|
2003-09-25 |
2006-07-04 |
Allergan, Inc. |
Method for imparting artificial tan to human skin
|
|
US20050112075A1
(en)
|
2003-11-25 |
2005-05-26 |
Hwang Cheng S. |
Reduction of hair growth
|
|
EP1722780A4
(de)
|
2003-11-26 |
2008-12-17 |
Univ Duke |
Verfahren zur prävention oder behandlung von glaukom
|
|
US7288029B1
(en)
|
2005-01-19 |
2007-10-30 |
Gkn Driveline North America, Inc. |
Propshaft with crash-worthiness
|
|
WO2006047466A2
(en)
|
2004-10-21 |
2006-05-04 |
Duke University |
Ophthamological drugs
|
|
GB0506759D0
(en)
|
2005-04-02 |
2005-05-11 |
Medical Res Council |
Combination treatment methods
|
|
WO2007123818A2
(en)
|
2006-04-18 |
2007-11-01 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of prostaglandins, compositions and methods of use
|
|
KR101281965B1
(ko)
|
2006-04-24 |
2013-07-03 |
제이에스알 가부시끼가이샤 |
중합체 및 이를 함유하는 감광성 수지 조성물
|
|
US20070254920A1
(en)
|
2006-04-26 |
2007-11-01 |
Aerie Pharmaceuticals, Inc. |
Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
|
|
US7868032B2
(en)
|
2006-10-18 |
2011-01-11 |
Allergan, Inc. |
Prostamide receptor antagonists
|
|
JP5095269B2
(ja)
|
2007-06-05 |
2012-12-12 |
北海道エア・ウォーター株式会社 |
通信システム
|
|
US20090018204A1
(en)
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
|
EP2349242B1
(de)
|
2008-10-29 |
2018-12-05 |
Novaer Holdings, Inc. |
Aminosäuresalze von prostaglandinen
|
|
US8722739B2
(en)
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
US8623918B2
(en)
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
WO2010108012A1
(en)
|
2009-03-18 |
2010-09-23 |
Duke University |
Compositions and methods for promoting nasal patency and treating neurogenic bladder using prostaglandins
|
|
JP5331025B2
(ja)
|
2010-02-18 |
2013-10-30 |
八千代工業株式会社 |
サンルーフ装置のガイドパイプの保持構造
|